//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
In this QA, Premal H. Thaker, MD, MS, of @washumedicine.bsky.social unpacks the role of CDK2 inhibition in platinum-resistant ovarian cancer. #oncology #PROC #ovariancancer Read more here: www.onclive.com/view/oral-ad...
Premal Thaker, MD, MS, discusses the role for CDK2 inhibition in platinum-resistant ovarian cancer.
www.onclive.com
Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer | OncLive
5h
OncLive